AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30

ANAVEX LIFE SCIENCES CORP.

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 28, 2026

$1.25−0.06 (-4.58%)

Close on Oct 19, 2026

Market cap: $116.12B
P/E (TTM): –
Dividend yield: –

ANAVEX LIFE SCIENCES CORP. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	Q3 2026 2026-06-30	Q2 2026 2026-03-31	Q1 2026 2025-12-31	Q4 2025 2025-09-30	Q3 2025 2025-06-30	Q2 2025 2025-03-31	Q1 2025 2024-12-31	Q4 2024 2024-09-30	Q3 2024 2024-06-30	Q2 2024 2024-03-31	Q1 2024 2023-12-31	Q4 2023 2023-09-30	Q3 2023 2023-06-30	Q2 2023 2023-03-31	Q1 2023 2022-12-31	Q4 2022 2022-09-30	Q3 2022 2022-06-30	Q2 2022 2022-03-31	Q1 2022 2021-12-31	Q4 2021 2021-09-30	Q3 2021 2021-06-30	Q2 2021 2021-03-31	Q1 2021 2020-12-31	Q4 2020 2020-09-30	Q3 2020 2020-06-30	Q2 2020 2020-03-31	Q1 2020 2019-12-31	Q4 2019 2019-09-30	Q3 2019 2019-06-30	Q2 2019 2019-03-31	Q1 2019 2018-12-31	Q4 2018 2018-09-30	Q3 2018 2018-06-30	Q2 2018 2018-03-31	Q1 2018 2017-12-31	Q4 2017 2017-09-30	Q3 2017 2017-06-30	Q2 2017 2017-03-31	Q1 2017 2016-12-31	Q4 2016 2016-09-30
Research & Development	–	4.19	4.66	7.29	9.96	9.89	10	12	12	9.73	8.68	10	10	11	12	11	9.27	8.60	8.66	9.37	8.96	6.72	7.93	6.10	6.73	6.05	6.35	4.71	5.76	6.08	5.71	4.41	3.00	3.25	2.69	3.84	2.30	2.49	2.04	3.37
Selling, General & Admin	2.03	2.29	2.13	3.55	4.50	2.62	3.15	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
General & Administrative	–	2.29	2.13	3.55	4.50	2.62	3.15	2.66	2.79	2.90	2.69	2.60	3.25	2.88	3.32	3.90	3.19	2.92	3.07	2.88	2.43	2.23	1.47	1.40	1.38	1.72	1.35	1.64	1.39	2.06	1.76	1.48	1.62	1.49	1.40	1.36	1.41	1.12	1.13	3.22
Operating Expenses	-6.74	6.48	6.78	11	14	13	14	14	15	13	11	13	14	14	15	15	12	12	12	12	11	8.95	9.40	-55	8.11	7.77	7.70	6.35	7.15	8.14	7.47	5.89	4.62	4.73	4.09	5.20	3.71	3.61	3.17	6.58
Operating Income	6.74	-6.48	-6.78	-11	-14	-13	-14	-14	-15	-13	-11	-13	-14	-14	-15	-15	-12	-12	-12	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Non-Operating Income	1.09	1.15	1.12	1.02	1.22	1.32	1.48	2.65	2.39	2.08	2.76	2.44	2.29	1.13	2.39	1.20	0.18	1.11	0.87	0.68	1.26	0.83	1.60	1.55	1.62	0.54	1.12	0.75	0.64	0.94	0.56	0.33	1.77	0.01	0.04	0.05	0.11	2.07	0.05	0.08
Pretax Income	–	–	–	–	–	–	–	-12	-12	-10	-8.54	-10	-11	-13	-13	-14	-12	-10	-11	-12	-10	-8.13	-7.80	-5.96	-6.48	-7.24	-6.58	-5.60	-6.50	-7.20	-6.91	-5.56	-2.85	-4.72	-4.05	-5.15	-3.60	-1.54	-3.12	-6.51
Income Tax Expense	0	0	0.02	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-12	-10	-11	–	-10	-8.16	-7.86	–	-6.49	-7.24	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Income	7.82	-5.34	-5.68	-9.83	-13	-11	-12	-12	-12	-11	-8.62	-10	-11	-13	-13	-14	-12	-10	-11	-12	-10	-8.16	-7.86	-5.97	-6.49	-7.24	-6.59	-5.61	-6.52	-7.25	-6.92	-5.59	-2.85	-4.75	-4.06	-5.15	-3.61	-1.55	-3.15	-6.51
Net Income to Common	7.82	–	–	–	-13	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
EPS (Basic)(per share)	0.08	-0.06	-0.06	-0.11	-0.16	-0.13	-0.14	-0.14	-0.14	-0.13	-0.11	-0.12	-0.14	-0.17	-0.17	–	–	–	-0.14	–	-0.14	-0.12	-0.12	-0.10	-0.11	-0.12	-0.12	-0.11	-0.13	-0.15	-0.15	-0.12	-0.06	-0.11	-0.09	-0.12	-0.04	-0.04	-0.08	-0.18
EPS (Diluted)(per share)	0.08	-0.06	-0.06	-0.11	-0.16	-0.13	-0.14	-0.14	-0.14	-0.13	-0.11	-0.12	-0.14	-0.17	-0.17	–	–	–	-0.14	–	-0.14	-0.12	-0.12	-0.10	-0.11	-0.12	-0.12	-0.11	-0.13	-0.15	-0.15	-0.12	-0.06	-0.11	-0.09	-0.12	-0.04	-0.04	-0.08	-0.18
Shares Outstanding (Basic, Weighted)(shares)	92,697	93	89	86	85,381	85	85	85	85	82	82	82	81	78	78	–	–	–	76	–	–	69	64	61	59	58	55	53	50	47	46	46	45	45	44	42	42	41	38	36
Shares Outstanding (Diluted, Weighted)(shares)	92,900	93	89	86	85,381	85	85	85	85	82	82	82	81	78	78	–	–	–	76	–	–	69	64	61	59	58	55	53	50	47	46	46	45	45	44	42	42	41	38	36
Net Interest Income	1.07	1.06	1.08	1.00	1.08	1.21	1.39	1.76	1.80	1.76	2.01	1.96	1.83	1.47	1.27	0.70	0.23	0.01	0.00	0.01	0.01	0.01	0.00	0.01	0.06	0.07	0.05	0.04	0.03	0.05	0.08	0.08	0.11	0.03	0.03	0.04	0.03	0.02	0.00	0.00

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -43.1%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: –
Price to book: 1032.70
Dividend yield: –